Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?
Eugenio Cavalli(Centro Neurolesi Bonino Pulejo), Maria Sofia Basile(University of Catania), Maria Cristina Petralia(University of Messina), Rita Bella(University of Catania), Katia Mangano(University of Catania), Rosella Ciurleo(Centro Neurolesi Bonino Pulejo), Placido Bramanti(Centro Neurolesi Bonino Pulejo), Ferdinando Nicoletti(University of Catania), Paolo Fagone(University of Catania)
Cited by 45
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
|Oncotarget|2011|579
GSK-3 as potential target for therapeutic intervention in cancer
|Oncotarget|2014|508
The neuropathic pain: An overview of the current treatment and future therapeutic approaches
|International Journal of Immunopathology and Pharmacology|2019|495